292 related articles for article (PubMed ID: 18280496)
21. Optimization of specificity in a cellular protein interaction network by negative selection.
Zarrinpar A; Park SH; Lim WA
Nature; 2003 Dec; 426(6967):676-80. PubMed ID: 14668868
[TBL] [Abstract][Full Text] [Related]
22. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
23. Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2.
Rasmussen RK; Ji H; Eddes JS; Moritz RL; Reid GE; Simpson RJ; Dorow DS
Electrophoresis; 1997; 18(3-4):588-98. PubMed ID: 9150946
[TBL] [Abstract][Full Text] [Related]
24. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
Kami K; Takeya R; Sumimoto H; Kohda D
EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
[TBL] [Abstract][Full Text] [Related]
25. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
[TBL] [Abstract][Full Text] [Related]
27. Ubc2, an ortholog of the yeast Ste50p adaptor, possesses a basidiomycete-specific carboxy terminal extension essential for pathogenicity independent of pheromone response.
Klosterman SJ; Martinez-Espinoza AD; Andrews DL; Seay JR; Gold SE
Mol Plant Microbe Interact; 2008 Jan; 21(1):110-21. PubMed ID: 18052888
[TBL] [Abstract][Full Text] [Related]
28. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands.
Tran T; Hoffmann S; Wiesehan K; Jonas E; Luge C; Aladag A; Willbold D
Biochemistry; 2005 Nov; 44(45):15042-52. PubMed ID: 16274251
[TBL] [Abstract][Full Text] [Related]
29. Versatile retargeting of SH3 domain binding by modification of non-conserved loop residues.
Hiipakka M; Saksela K
FEBS Lett; 2007 May; 581(9):1735-41. PubMed ID: 17418138
[TBL] [Abstract][Full Text] [Related]
30. Identification of an SH3-binding motif in a new class of methionine aminopeptidases from Mycobacterium tuberculosis suggests a mode of interaction with the ribosome.
Addlagatta A; Quillin ML; Omotoso O; Liu JO; Matthews BW
Biochemistry; 2005 May; 44(19):7166-74. PubMed ID: 15882055
[TBL] [Abstract][Full Text] [Related]
31. The biologically relevant targets and binding affinity requirements for the function of the yeast actin-binding protein 1 Src-homology 3 domain vary with genetic context.
Haynes J; Garcia B; Stollar EJ; Rath A; Andrews BJ; Davidson AR
Genetics; 2007 May; 176(1):193-208. PubMed ID: 17409071
[TBL] [Abstract][Full Text] [Related]
32. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
33. Recognition specificity of individual EH domains of mammals and yeast.
Paoluzi S; Castagnoli L; Lauro I; Salcini AE; Coda L; Fre' S; Confalonieri S; Pelicci PG; Di Fiore PP; Cesareni G
EMBO J; 1998 Nov; 17(22):6541-50. PubMed ID: 9822599
[TBL] [Abstract][Full Text] [Related]
34. The design of a hyperstable mutant of the Abp1p SH3 domain by sequence alignment analysis.
Rath A; Davidson AR
Protein Sci; 2000 Dec; 9(12):2457-69. PubMed ID: 11206067
[TBL] [Abstract][Full Text] [Related]
35. Interaction with the SH3 domain protein Bem1 regulates signaling by the Saccharomyces cerevisiae p21-activated kinase Ste20.
Winters MJ; Pryciak PM
Mol Cell Biol; 2005 Mar; 25(6):2177-90. PubMed ID: 15743816
[TBL] [Abstract][Full Text] [Related]
36. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
[TBL] [Abstract][Full Text] [Related]
37. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
Pisabarro MT; Serrano L
Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
[TBL] [Abstract][Full Text] [Related]
38. The common phospholipid-binding activity of the N-terminal domains of PEX1 and VCP/p97.
Shiozawa K; Goda N; Shimizu T; Mizuguchi K; Kondo N; Shimozawa N; Shirakawa M; Hiroaki H
FEBS J; 2006 Nov; 273(21):4959-71. PubMed ID: 17018057
[TBL] [Abstract][Full Text] [Related]
39. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
40. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
